(BPT) - If you’re diagnosed with cancer, chances are that you will turn to a community oncologist. According to the American Cancer Society, an estimated 1.7 million Americans will be diagnosed …
This item is available in full to subscribers.
We have recently launched a new and improved website. To continue reading, you will need to either log into your subscriber account, or purchase a new subscription.
If you are a digital subscriber with an active subscription, or you are a print subscriber who had access to our previous wesbite, then you already have an account here. Just reset your password if you have not yet logged in to your account on this new site.
If you are a current print subscriber and did not have a user account on our previous website, you can set up a free website account by clicking here.
Otherwise, click here to view your options for subscribing.
Please log in to continue |
(BPT) - If you’re diagnosed with cancer, chances are that you will turn to a community oncologist. According to the American Cancer Society, an estimated 1.7 million Americans will be diagnosed with cancer in 2019.1 For many of these Americans, seeing a community oncologist is often the first step toward starting a treatment regimen to help fight the disease. Almost 55% of all Americans diagnosed with cancer will be treated by an oncologist in their community.2Undergoing treatment by a local or community oncologist can often mean receiving personalized care close to home and may lead to lower costs and easier access to monitored care.2,3 Additionally, community-based care may limit disruption to your day-to-day life and can keep you closer to your family and friends during treatment.2Since community oncologists see and treat patients diagnosed with a broad range of cancers, providing opportunities to discuss the latest research – known as scientific exchange – is important. This summer, community oncologists will be meeting with other experts in the field for the “Best of ASCO” regional meetings. These meetings, which are hosted by the world’s leading oncology professional organization – the American Society of Clinical Oncology (ASCO) – bring information shared during the organization’s annual meeting, where 32,000 oncology professionals from around the world discuss more than 2,500 pieces on the latest in cancer research, directly to the local community. For this year’s “Best of ASCO” Program, ASCO has selected 70 of the top “practice-changing” pieces of research across a variety of cancers to share in meetings in three cities taking place across the country.Findings on acute myeloid leukemia, advanced prostate cancer and advanced bladder cancer will be presented at the meeting. Astellas, a company dedicated to making every day better for those impacted by cancer, is one of the companies with research being featured at these meetings.Andrew Krivoshik, M.D., Ph.D., Senior Vice President and Oncology Therapeutic Area Head at Astellas, shares: “Due to their role in the care of patients, community oncologists are critical to helping us realize our vision of advancing science to deliver medicines to the people most in need. For this reason, we are proud to share the latest research on certain Astellas medicines and investigational therapies directly with these physicians.”For more information on the “Best of ASCO” Program, visit: https://meetings.asco.org/boa/join-us. For more information on Astellas Oncology, visit: http://www.astellasoncology.com/.References